Search
09/01/2024
Tofacitinib Use in the Treatment of Plantar Erosive Lichen Planus.
Mateu-Arrom L, Garcia-Muret MP, Conforto GC, Puig L. Tofacitinib Use in the Treatment of Plantar Erosive Lichen Planus.. INDIAN JOURNAL OF DERMATOLOGY. 2024; 68(6)DOI:10.4103/ijd.ijd_512_23. PMID:38371534. IF:(Q/D).
08/01/2024
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer
Steinberg, GD, Shore, ND, Redorta, JP, Galsky, MD, Bedke, J, Ku, JH, Kretkowski, M, Hu, HL, Penkov, K, Vermette, JJ, Tarazi, JC, Randall, AE, Pierce, KJ, Saltzstein, D, Powles, TB. CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer. Future Oncology. 2024; 20(14)DOI:10.2217/fon-2023-0271. PMID:38189180. IF:2.600(Q3/6D).
08/01/2024
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Contreras-Toledo, D, Jiménez-Fonseca, P, López, CL, Montes, AF, Muñoz, AML, Rivera, FV, Alonso, V, Alcaide, J, Salvà, F, Rúa, MC, Guillot, M, Carnicero, AM, Mate, RJ, García, SC, Martínez, EA, Astorga, BG, Fernandez-Diaz, AB, Villaroel, PG, Manrique, ACV, Sosa, MM, Alonso, B, Castiñeiras, AC, López, CC, Aparicio, J, Carmona-Bayonas, A. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?. BRITISH JOURNAL OF CANCER. 2024; 130(5)DOI:10.1038/s41416-023-02563-w. PMID:38191609. IF:6.800(Q1/2D).
06/01/2024
Painful flesh-coloured papules in a middle-aged woman
Carmona-Rocha, E, Rusiñol, L, Yélamos, O. Painful flesh-coloured papules in a middle-aged woman. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 49(6)DOI:10.1093/ced/llae007. PMID:38183665. IF:2.800(Q2/4D).
05/01/2024
Pustules, arthritis, and fever in a patient with Crohn's disease
Alturo-Pons, A, Carmona-Rocha, E, Rusiñol, L, Iznardo, H, Puig, L. Pustules, arthritis, and fever in a patient with Crohn's disease. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(6)DOI:10.1111/ijd.17003. PMID:38183159. IF:3.200(Q1/3D).
05/01/2024
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases
del Pozo, V, Bobolea, I, Rial, MJ, Espigol-Frigolé, G, Laqué, RS, Hernández-Rivas, JM, Mora, E, Crespo-Lessmann, A, Alonso, JLI, Sosa, MSD, Maza-Solano, J, Atienza-Mateo, B, Bañas-Conejero, D, Moure, AL, Rúa-Figueroa, I. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases. Frontiers in Immunology. 2024; 14DOI:10.3389/fimmu.2023.1310211. PMID:38250075. IF:5.900(Q1/2D).
04/01/2024
Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective
Lomonte, C, Rossini, M, Ibeas, J, Forcella, M, Ponikvar, JB, Gallieni, M, Russo, R, Goumenos, D, Tesar, V, Hruskova, Z, Roelofs, J, Florquin, S, Snoeijs, M, Giusto, A, Shemesh, D, Rotmans, J, Torra, R, Wanner, C, Gesualdo, L. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective. Clinical Kidney Journal. 2024; 17(1)DOI:10.1093/ckj/sfad299. PMID:38213498. IF:4.600(Q1/2D).
04/01/2024
Severe sperm DNA fragmentation may persist for up to 3 years after cytotoxic therapy in patients affected by Hodgkin lymphoma and non-Hodgkin lymphoma
Farnetani, G, Vannucci, M, Fino, MG, Cioppi, F, Rosta, V, Palma, M, Tamburrino, L, Vinci, S, Casamonti, E, Degl'Innocenti, S, Spinelli, M, Abrardo, C, Marchiani, S, Lotti, F, Muratori, M, Riera-Escamilla, A, Krausz, C. Severe sperm DNA fragmentation may persist for up to 3 years after cytotoxic therapy in patients affected by Hodgkin lymphoma and non-Hodgkin lymphoma. HUMAN REPRODUCTION. 2024; 39(3)DOI:10.1093/humrep/dead269. PMID:38177083. IF:6.100(Q1/1D).
04/01/2024
Capecitabine-Related Thrombotic Microangiopathy
Mateo, FJP, Guasch, AD, Pineda, JAG, Manrique, ACV, Cullell, BM, López-Bravo, DP, Díaz, JG, Cascón, AP, Freiria, XB. Capecitabine-Related Thrombotic Microangiopathy. Journal Of Gastrointestinal Cancer. 2024; 55(2)DOI:10.1007/s12029-023-00993-6. PMID:38175385. IF:(Q/D).
03/01/2024
High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery
Isand, K, Feelders, R, Brue, T, Toth, M, Deutschbein, T, Reincke, M, Krsek, M, Santos, A, Demtröder, F, Chabre, O, Strasburger, CJ, Maso, AA, Volke, V, Pereira, AM, Lohmann, R, Saladich, IG, Webb, SM, Wass, J, Valassi, E. High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2024; 190(1)DOI:10.1093/ejendo/lvad176. PMID:38146835. IF:5.200(Q1/2D).
03/01/2024
Oligometastatic disease: a need for consensus to cure the incurable in a multidisciplinary approach
Martinez-Recio, S, Barba, A, Farré, N, Majem, M. Oligometastatic disease: a need for consensus to cure the incurable in a multidisciplinary approach. Chinese Clinical Oncology. 2024; 13(2)DOI:10.21037/cco-23-118. PMID:38199796. IF:(Q/D).
03/01/2024
Evaluation of bone-related mechanical properties in female patients with long-term remission of Cushing's syndrome using quantitative computed tomography-based finite element analysis
Giuliodori, A, Soudah, E, Malouf, J, Martel-Duguech, L, Amodru, V, Gil, J, Hernandez, JA, Domingo, MP, Webb, SM, Valassi, E. Evaluation of bone-related mechanical properties in female patients with long-term remission of Cushing's syndrome using quantitative computed tomography-based finite element analysis. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2024; 190(1)DOI:10.1093/ejendo/lvae004. PMID:38285633. IF:5.200(Q1/2D).
02/01/2024
Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal-Lobe Signs
Ruiz-Barrio, I, Horta-Barba, A, Aracil-Bolaños, I, Martinez-Horta, S, Kulisevsky, J, Pagonabarraga, J. Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal-Lobe Signs. Movement Disorders Clinical Practice. 2024; 11(3)DOI:10.1002/mdc3.13958. PMID:38164060. IF:2.700(Q2/5D).
02/01/2024
Durability and long-term outcomes of biologic therapies in psoriasis
Rusinol, L, Carmona-Rocha E., Puig L.. Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology. 2024; 20(1)DOI:10.1080/1744666X.2023.2250918. PMID:37610817. IF:3.700(Q2/5D).
02/01/2024
Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis
Nomah, DK, Díaz, Y, Bruguera, A, Moreno-Fornés, S, Aceiton, J, Reyes-Urueña, J, Llibre, JM, Falcó, V, Imaz, A, Fanjul, FJ, Peraire, J, Deig, E, Domingo, P, Inciarte, A, Casabona, J, Miró, JM. Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis. Open Forum Infectious Diseases. 2024; 11(1)DOI:10.1093/ofid/ofad693. PMID:38221982. IF:3.800(Q1/3D).
01/01/2024
Magnetic resonance imaging-based criteria to differentiate dysferlinopathy from other genetic muscle diseases
Bolano-Diaz, C, Verdú-Díaz, J, Gonzalez-Chamorro, A, Fitzsimmons, S, Veeranki, G, Straub, V, Diaz-Manera, J. Magnetic resonance imaging-based criteria to differentiate dysferlinopathy from other genetic muscle diseases. NEUROMUSCULAR DISORDERS. 2024; 34DOI:10.1016/j.nmd.2023.11.004. PMID:38007344. IF:2.800(Q2/5D).
01/01/2024
Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis (Journal of Neurology, (2023), 270, 12, (5849-5865), 10.1007/s00415-023-11862-4)
Esteller D., Schiava M., Verdú-Díaz J., Villar-Quiles R.-N., Dibowski B., Venturelli N., Laforet P., Alonso-Pérez J., Olive M., Domínguez-González C., Paradas C., Vélez B., Kostera-Pruszczyk A., Kierdaszuk B., Rodolico C., Claeys K., Pál E., Malfatti E., Souvannanorath S., Alonso-Jiménez A., de Ridder W., De Smet E., Papadimas G., Papadopoulos C., Xirou S., Luo S., Muelas N., Vilchez J.J., Ramos-Fransi A., Monforte M., Tasca G., Udd B., Palmio J., Sri S., Krause S., Schoser B., Fernández-Torrón R., López de Munain A., Pegoraro E., Farrugia M.E., Vorgerd M., Manousakis G., Chanson J.B., Nadaj-Pakleza A., Cetin H., Badrising U., Warman-Chardon J., Bevilacqua J., Earle N., Campero M., Díaz J., Ikenaga C., Lloyd T.E., Nishino I., Nishimori Y., Saito Y., Oya Y., Takahashi Y., Nishikawa A., Sasaki R., Marini-Bettolo C., Guglieri M., Straub V., Stojkovic T., Carlier R.Y., Díaz-Manera J.. Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis (Journal of Neurology, (2023), 270, 12, (5849-5865), 10.1007/s00415-023-11862-4). JOURNAL OF NEUROLOGY. 2024; 271(4)DOI:10.1007/s00415-023-12178-z. PMID:38349561. IF:4.600(Q1/2D).
01/01/2024
Baseline Large-Scale Network Dynamics Associated with Disease Progression in Huntington's Disease
Aracil-Bolaños, I, Pérez-Pérez, J, Martínez-Horta, S, Horta-Barba, A, Puig-Davi, A, Garcia-Cornet, J, Olmedo-Saura, G, Campolongo, A, Pagonabarraga, J, Kulisevsky, J. Baseline Large-Scale Network Dynamics Associated with Disease Progression in Huntington's Disease. MOVEMENT DISORDERS. 2024; 39(1)DOI:10.1002/mds.29655. PMID:38148511. IF:7.600(Q1/1D).
01/01/2024
Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease
Rodríguez-Antigüedad J., Martínez-Horta S., Horta-Barba A., Puig-Davi A., Campolongo A., Sampedro F., Bejr-Kasem H., Marín-Lahoz J., Pagonabarraga J., Kulisevsky J.. Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease. JOURNAL OF NEURAL TRANSMISSION. 2024; 131(12)DOI:10.1007/s00702-023-02725-3. PMID:38206439. IF:4.000(Q1/2D).
01/01/2024
Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data
Efthimiou O., Taipale H., Radua J., Schneider-Thoma J., Pinzón-Espinosa J., Ortuño M., Vinkers C.H., Mittendorfer-Rutz E., Cardoner N., Tanskanen A., Fusar-Poli P., Cipriani A., Vieta E., Leucht S., Tiihonen J., Luykx J.J.. Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. LANCET PSYCHIATRY. 2024; 11(2)DOI:10.1016/S2215-0366(23)00366-8. PMID:38215784. IF:24.800(Q1/1D).